University of Cincinnati

What you'll study

The programme centres on original research combined with advanced coursework to provide a mechanistic understanding of drug action and toxic responses at molecular, cellular and systems levels. Students complete core courses in pharmacology, toxicology, molecular and cellular biology, and biostatistics, and choose advanced electives aligned with their research focus.

• Core topics: receptor pharmacology, drug metabolism, toxicokinetics/toxicodynamics, signal transduction, molecular pharmacology and experimental therapeutics.
• Research methods: in vivo pharmacology, cell culture, omics technologies, high-content screening, imaging, analytical chemistry approaches (e.g. LC-MS) and computational modelling relevant to pharmacology and toxicology.
• Translational themes: drug discovery and development, safety assessment, biomarker development, neuropharmacology, cardiovascular pharmacology, cancer pharmacology and environmental toxicology.
• Training components: laboratory rotations in different faculty labs, seminar participation, journal clubs, teaching assistantships and a required qualifying examination leading to dissertation research.

Students spend the majority of the programme conducting a supervised research project that culminates in a doctoral dissertation and public defence. Formal coursework is integrated with mentoring, grant-writing exercises and opportunities to present at local and national meetings.

Entry requirements

Applicants are typically expected to hold a Bachelor’s degree with strong science content (for example, biology, pharmacology, toxicology, chemistry or a related discipline); many successful applicants hold a relevant Master's degree. Typical application components include:

• Academic transcripts demonstrating strong performance in undergraduate and any postgraduate study.
• Letters of recommendation from academic or professional referees who can speak to research potential.
• A personal statement outlining research interests, prior laboratory experience and career goals.
• Evidence of research experience, such as publications, conference presentations or detailed descriptions of past laboratory projects.
• Proof of English language proficiency for applicants whose first language is not English, by the tests accepted by the university.

The programme may consider GRE scores where provided but does not rely on a single test score alone. Admissions decisions are typically based on the overall strength of the academic record, research experience and fit with available faculty mentors. Prospective students are encouraged to contact potential supervisors to discuss research alignment before applying.

Career prospects

Graduates are prepared for a range of scientific careers that require deep expertise in drug action and safety science. Common career paths include:

• Academic research and teaching positions (postdoctoral training followed by faculty roles).
• Drug discovery and development roles in pharmaceutical and biotechnology companies, including pharmacology, toxicology, assay development and preclinical safety teams.
• Regulatory science and safety assessment positions at government agencies, contract research organisations (CROs) and consultancies.
• Translational research roles in clinical research organisations, medical centres or partnerships between academia and industry.
• Specialist positions in toxicological risk assessment, environmental health, or intellectual property and science policy where deep technical knowledge is required.

Alumni typically combine technical expertise with skills in experimental design, data analysis, communication and project management, making them competitive for leadership roles in multidisciplinary teams.

Why study at University of Cincinnati

The University of Cincinnati offers an environment where pharmacology and toxicology research is embedded within strong biomedical and clinical partnerships. Students benefit from access to core research facilities, advanced instrumentation and collaborative links with the university medical centre and affiliated hospitals.

• Interdisciplinary research: opportunities to work across neuroscience, cancer biology, cardiovascular science and drug discovery projects.
• Experienced faculty: mentors with active programmes in preclinical pharmacology, mechanistic toxicology and translational therapeutics.
• Professional development: structured training in grant writing, scientific communication and teaching, plus chances to present at symposia and conferences.
• Resources and infrastructure: access to animal facilities, imaging suites, analytical chemistry cores and bioinformatics support to advance complex research programmes.

These elements combine to support rigorous doctoral training aimed at producing independent researchers capable of addressing contemporary challenges in drug development and safety science.